Skip to main content
lexblog.com/lib/W6HR8E4Bviewrecordjson
LEX-WK-W6HR8E4Bcrawled 2025-06-23 08:22Z

FDA Approves Celltrion’s New Pediatric Formulation of STEQEYMA, Expanding Dosing Flexibility

Yoko Bian · Big Molecule Watch · Published June 23, 2025

Work details

author
Yoko Bian
firm or organization
Goodwin Procter
published
2025-06-23

Citation

Yoko Bian, FDA Approves Celltrion’s New Pediatric Formulation of STEQEYMA, Expanding Dosing Flexibility, Big Molecule Watch (June 23, 2025) [The Library at LexBlog, LEX-WK-W6HR8E4B, lexpid.org/W6HR8E4B]